Search Results - Pascal Demoly
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Exploring the pathogenesis and clinical implications of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO): a narrative review by Kantapat Simmalee, Theerasuk Kawamatawong, Joana Vitte, Pascal Demoly, Putthapoom Lumjiaktase
Published in Frontiers in Medicine (2025-04-01)Get full text
Article -
6
-
7
-
8
The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study by Pascal Demoly, Christophe Leroyer, Elie Serrano, Annelore Le Maux, Gabrielle Magnier, Antoine Chartier
Published in Clinical and Translational Allergy (2022-03-01)Get full text
Article -
9
-
10
-
11
-
12
New Keratoconus Risk Factors: A Cross-Sectional Case—Control Study by Eloi Debourdeau, Gabriel Planells, Chloe Chamard, David Touboul, Max Villain, Pascal Demoly, Fanny Babeau, Pierre Fournie, Vincent Daien
Published in Journal of Ophthalmology (2022-01-01)Get full text
Article -
13
Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic by Philippe Devillier, MD, PhD, Sarah Saf, MD, Christine Rolland, BA, Giorgio Walter Canonica, MD, Pascal Demoly, MD, PhD
Published in World Allergy Organization Journal (2024-04-01)Get full text
Article -
14
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in conte... by Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Philippe Devillier
Published in The Lancet Regional Health. Europe (2024-06-01)Get full text
Article -
15
Correction to “Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)”... by Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Philippe Devillier
Published in The Lancet Regional Health. Europe (2024-11-01)Get full text
Article -
16
Drug allergy in primary care: systematic review to support quality of management and optimization of healthcare pathways by Clara Gaudin, Myriam Mamodaly, Janwillem Kocks, Jantina Van Der Velde, Bertine De Flokstra Blok, Elisabeth Angier, Radek Gawlik, Dermot Ryan, Pascal Demoly, Luciana Kase Tanno
Published in World Allergy Organization Journal (2020-08-01)Get full text
Article -
17
The Primary Care and Environmental Health e-Learning Course to Integrate Environmental Health in General Practice: Before-and-After Feasibility Study by Jean-Baptiste Tostain, Marina Mathieu, Agnès Oude Engberink, Bernard Clary, Michel Amouyal, Béatrice Lognos, Pascal Demoly, Isabella Annesi-Maesano, Grégory Ninot, Nicolas Molinari, Arnaud Richard, Maha Badreddine, Claire Duflos, Francois Carbonnel
Published in JMIR Formative Research (2024-05-01)Get full text
Article -
18
Are symptoms of insomnia related to respiratory symptoms? Cross-sectional results from 10 European countries and Australia by Thorarinn Gislason, Joachim Heinrich, Pascal Demoly, Rain Jogi, Kjell Torén, Jennifer L Perret, Debbie Jarvis, Judith Garcia Aymerich, Eva Lindberg, Christer Janson, Erla Bjornsdottir, Bryndis Benediktsdottir, Vanessa Garcia Larsen, Karl Franklin, Sandra Dorado Arenas
Published in BMJ Open (2020-04-01)Get full text
Article -
19
Association between physical activity over a 10-year period and current insomnia symptoms, sleep duration and daytime sleepiness: a European population-based study by Thorarinn Gislason, Joachim Heinrich, Pascal Demoly, Rain Jogi, Kjell Torén, Jennifer L Perret, Debbie Jarvis, Judith Garcia Aymerich, Eva Lindberg, Christer Janson, Erla Bjornsdottir, Bryndis Benediktsdottir, Vanessa Garcia Larsen, Karl Franklin, Sandra Dorado-Arenas, Elin Helga Thorarinsdottir
Published in BMJ Open (2024-03-01)Get full text
Article -
20
Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data by Margitta Worm, MD, Pascal Demoly, MD, PhD, Yoshitaka Okamoto, MD, PhD, Carmen Vidal, MD, PhD, Katia Daghildjian, PharmD, PhD, Kwok Yan, MD, Thomas B. Casale, MD, Karl-Christian Bergmann, MD, PhD
Published in World Allergy Organization Journal (2024-07-01)Get full text
Article
